CH
Cheturam Hassanand Kukreja
About Cheturam Hassanand Kukreja
Data last updated:
Cheturam Hassanand Kukreja is a Director at Adroit Pharmaceuticals Private Limited (since 1981). The company operates in Pharma. Adroit Pharmaceuticals Private Limited reported revenue of ₹80.51 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Adroit Pharmaceuticals Private Limited U24239MH1977PTC019620 | Director | 19 Oct 1981 | 1977 | ₹80.51 Cr (FY 2024) | Active |
Board colleagues of Cheturam Hassanand Kukreja
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhimanyu Hassanand Kukreja | 03224925 | Adroit Pharmaceuticals Private Limited | Director |
| Bhupendra Abhimanyu Kukreja | 00868830 | Adroit Pharmaceuticals Private Limited | Director |
| Ghanshyamdas Hassanand Kukreja | 03020822 | Adroit Pharmaceuticals Private Limited | Director |
| Sanjay Kukreja Cheturam | 02289553 | Adroit Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Cheturam Hassanand Kukreja
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cheturam Hassanand Kukreja
Cheturam Hassanand Kukreja currently holds 1 directorship: Adroit Pharmaceuticals Private Limited (Director, since 19 Oct 1981, revenue ₹80.51 Cr (FY 2024)).
Cheturam Hassanand Kukreja was first appointed on 19 Oct 1981 as Director at Adroit Pharmaceuticals Private Limited.
The current boards of Cheturam Hassanand Kukreja's companies include Abhimanyu Hassanand Kukreja (Adroit Pharmaceuticals Private Limited), Bhupendra Abhimanyu Kukreja (Adroit Pharmaceuticals Private Limited), Ghanshyamdas Hassanand Kukreja (Adroit Pharmaceuticals Private Limited), Sanjay Kukreja Cheturam (Adroit Pharmaceuticals Private Limited).